Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines
Cambridge- April, 2024- Moderna announced a contract with the Ministry of Health in Brazil (Ministรฉrio da Saรบde) to supply its mRNA COVID-19 vaccine as an integral... Read more.
WHO-trained journalists win national road safety reporting award in Viet Nam
WHO-trained journalists have won first prize in Viet Namโs annual national road safety media award. The interactive set of stories on disability inclusive transport... Read more.
7th Emirates Family Medicine Society Congress witnessed effective specialized participationย
Dubai, UAE- April 2024-The 7th Emirates Family Medicine Society Congress 2024, held at the Dubai World Trade Center under the patronage of His Excellency Sheikh... Read more.
MEDCARE WOMEN & CHILDREN HOSPITAL leads the way in advanced Gene Therapy
Dubai- April, 2024- Medcare Women & Children Hospital (MWCH) in Dubai has announced reaching a milestone record of administering 100 gene therapy infusions on... Read more.
New Research by SGU Faculty Could Impact Global Heart Health Treatments
Dubai, UAE- April 2024- Dr. Rohit Mishra and Dr. Aishwarya Singh, two faculty members at St. George’s University (SGU), School of Medicine in the Caribbean... Read more.
Sidra Medicine Leads Largest Research on Rare Genetic Disease Risk in the Middle East
Doha, Qatar- 22 April 2024- The prestigious Genome Medicine journal has published a study by Sidra Medicine, a member of Qatar Foundation, on rare genetic diseases... Read more.
Hikma appoints Dr. Hafrun Fridriksdottir as President of Generics business
London- April 2024- Hikma Pharmaceuticals PLC announces the appointment of Dr. Hafrun Fridriksdottir as President of its Generics business. Hafrun will report to... Read more.
Viatris Appoints Corinne Le Goff as Chief Commercial Officer
Pittsburgh- 15 April 2024- Viatris announced that Corinne Le Goff has joined the company as Chief Commercial Officer and will become a member of the company’s... Read more.
U.S. FDA Approves Subcutaneous Administration of Takedaโs ENTYVIOยฎ (vedolizumab)
Osaka, Japan- April 2024- Takeda announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIOยฎ (vedolizumab) subcutaneous (SC) administration... Read more.
FDA approves Alecensa as first adjuvant treatment for people with ALK-positive early-stage lung cancer
Basel- April 2024- Roche announced that the U.S. Food and Drug Administration (FDA) has approved Alecensaยฎ (alectinib) for adjuvant treatment following tumour resection... Read more.